Emergent BioSolutions (EBS) Gross Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Gross Margin of 53.88% for Q1 2026, down 630.0% year-over-year from 10.17% in Q1 2025, and up 25.57% quarter-over-quarter from 42.91% in Q4 2025.
Emergent BioSolutions (EBS) Gross Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Gross Margin history runs 16 years deep, the most recent figure standing at 53.88% for Q1 2026.
- In Q1 2026, Gross Margin fell 630.0% year-over-year to 53.88%; the TTM figure through Mar 2026 stood at 54.24% (up 408.0% YoY), while the FY2025 annual figure was 56.09%, up 2137.0% from the prior year.
- Gross Margin for Q1 2026 stood at 53.88%, up from 42.91% in the prior quarter.
- The five-year high for Gross Margin was 73.65% in Q1 2022, with the low at 6.94% in Q1 2023.
- The 5-year median for Gross Margin is 50.6% (2022), against an average of 48.05%.
- The sharpest annual moves came in 2023 and 2024: Gross Margin sank 6672 bps in 2023, then soared 4493 bps in 2024.
- Emergent BioSolutions' Gross Margin stood at 49.33% in 2022, then plunged by 33 bps to 33.08% in 2023, then grew by 19 bps to 39.39% in 2024, then grew by 9 bps to 42.91% in 2025, then rose by 26 bps to 53.88% in 2026.
- Business Quant data shows EBS's Gross Margin at 53.88% in Q1 2026, 42.91% in Q4 2025, and 62.83% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.23 Bn | 43.26 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.48 Bn | 39.82 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.99 Bn | 30.32 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.30 Bn | 19.64 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 12.00 Bn | 11.47 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.92 Bn | - | - |
| 10 | Emergent BioSolutions | 253.61 Mn | 112.71 Mn | 137.20 Mn | 58.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58.56% |
| Mar 31, 2026 | 53.88% |
| Dec 31, 2025 | 42.91% |
| Sep 30, 2025 | 62.83% |
| Jun 30, 2025 | 52.52% |
| Mar 31, 2025 | 60.17% |
| Dec 31, 2024 | 39.39% |
| Sep 30, 2024 | 58.27% |
| Mar 31, 2024 | 51.86% |
| Dec 31, 2023 | 33.08% |
| Sep 30, 2023 | 34.64% |
| Jun 30, 2023 | 43.59% |
| Mar 31, 2023 | 6.94% |
| Dec 31, 2022 | 49.33% |
| Sep 30, 2022 | 38.64% |
| Jun 30, 2022 | 67.11% |
| Mar 31, 2022 | 73.65% |
| Dec 31, 2021 | 99.75% |
| Sep 30, 2021 | 87.15% |
| Jun 30, 2021 | 78.43% |